Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.66)
# 799
Out of 5,090 analysts
137
Total ratings
55.22%
Success rate
4.57%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVH Evolent Health | Maintains: Outperform | $18 → $12 | $3.94 | +204.57% | 1 | Nov 12, 2025 | |
| HCA HCA Healthcare | Maintains: Outperform | $400 → $500 | $486.70 | +2.73% | 12 | Oct 27, 2025 | |
| GRDN Guardian Pharmacy Services | Initiates: Outperform | $30 | $29.76 | +0.81% | 1 | Oct 10, 2025 | |
| CHE Chemed | Maintains: Outperform | $650 → $580 | $421.97 | +37.45% | 13 | Jul 31, 2025 | |
| UNH UnitedHealth Group | Maintains: Outperform | $400 → $325 | $330.91 | -1.79% | 17 | Jul 30, 2025 | |
| CNC Centene | Maintains: Outperform | $51 → $43 | $38.34 | +12.15% | 19 | Jul 28, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $257.85 | +20.22% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $265.44 | +41.27% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $7.59 | +58.10% | 11 | Jan 24, 2025 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $29.12 | +27.06% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $165 → $168 | $177.97 | -5.60% | 8 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $140 → $145 | $113.19 | +28.10% | 10 | Sep 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $32 → $40 | $30.76 | +30.04% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.57 | +40.06% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $9.33 | - | 2 | Mar 7, 2024 |
Evolent Health
Nov 12, 2025
Maintains: Outperform
Price Target: $18 → $12
Current: $3.94
Upside: +204.57%
HCA Healthcare
Oct 27, 2025
Maintains: Outperform
Price Target: $400 → $500
Current: $486.70
Upside: +2.73%
Guardian Pharmacy Services
Oct 10, 2025
Initiates: Outperform
Price Target: $30
Current: $29.76
Upside: +0.81%
Chemed
Jul 31, 2025
Maintains: Outperform
Price Target: $650 → $580
Current: $421.97
Upside: +37.45%
UnitedHealth Group
Jul 30, 2025
Maintains: Outperform
Price Target: $400 → $325
Current: $330.91
Upside: -1.79%
Centene
Jul 28, 2025
Maintains: Outperform
Price Target: $51 → $43
Current: $38.34
Upside: +12.15%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $257.85
Upside: +20.22%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $265.44
Upside: +41.27%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $7.59
Upside: +58.10%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $29.12
Upside: +27.06%
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $177.97
Upside: -5.60%
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $113.19
Upside: +28.10%
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $30.76
Upside: +30.04%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.57
Upside: +40.06%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $9.33
Upside: -